Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Toronto - Delayed Quote CAD

Medical Facilities Corporation (DR.TO)

Compare
16.59
-0.12
(-0.72%)
At close: April 1 at 4:00:00 PM EDT
Loading Chart for DR.TO
  • Previous Close 16.71
  • Open 16.56
  • Bid 16.60 x --
  • Ask 16.64 x --
  • Day's Range 16.44 - 17.08
  • 52 Week Range 10.47 - 17.97
  • Volume 131,641
  • Avg. Volume 97,577
  • Market Cap (intraday) 324.331M
  • Beta (5Y Monthly) 0.46
  • PE Ratio (TTM) 8.46
  • EPS (TTM) 1.96
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield 0.36 (2.15%)
  • Ex-Dividend Date Mar 31, 2025
  • 1y Target Est 16.36

Medical Facilities Corporation, through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States. The company's specialty hospital offers non-emergency surgical, imaging, diagnostic, and pain management procedures, as well as other ancillary services, such as primary and urgent care; and ambulatory surgery centers offers scheduled outpatient surgical procedures. Medical Facilities Corporation was incorporated in 2004 and is headquartered in Toronto, Canada.

www.medicalfacilitiescorp.ca

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DR.TO

View More

Performance Overview: DR.TO

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

DR.TO
9.05%
S&P/TSX Composite index (^GSPTSE)
1.68%

1-Year Return

DR.TO
62.35%
S&P/TSX Composite index (^GSPTSE)
12.84%

3-Year Return

DR.TO
61.66%
S&P/TSX Composite index (^GSPTSE)
14.03%

5-Year Return

DR.TO
486.33%
S&P/TSX Composite index (^GSPTSE)
94.41%

Compare To: DR.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DR.TO

View More

Valuation Measures

Annual
As of 4/1/2025
  • Market Cap

    324.33M

  • Enterprise Value

    274.87M

  • Trailing P/E

    8.52

  • Forward P/E

    11.79

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.84

  • Price/Book (mrq)

    1.86

  • Enterprise Value/Revenue

    0.58

  • Enterprise Value/EBITDA

    2.33

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    22.17%

  • Return on Assets (ttm)

    9.26%

  • Return on Equity (ttm)

    42.74%

  • Revenue (ttm)

    331.53M

  • Net Income Avi to Common (ttm)

    24.72M

  • Diluted EPS (ttm)

    1.96

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    108.5M

  • Total Debt/Equity (mrq)

    50.14%

  • Levered Free Cash Flow (ttm)

    72.09M

Research Analysis: DR.TO

View More

Company Insights: DR.TO

Research Reports: DR.TO

View More

People Also Watch